$XSNX News
Last published 3y ago
- 3y agoXSNXDr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardACCESS NewswireDr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardCLEVELAND, OH / ACCESSWIRE / March 15, 2023 / NovAccess Global Inc. , a biomedical company developing novel
- 3y agoXSNXNovAccess Global to Present at World Orphan Drug CongressACCESS NewswireCLEVELAND, OH / ACCESSWIRE / February 16, 2023 / NovAccess Global Inc. , a biomedical company developing novel immunotherapies for brain tumor patients, today announced that its CEO Dr. Dwain Irvin has been
- 4y agoXSNXNovAccess Global Announces Fireside Chat Series for the Investment CommunityACCESS NewswireCLEVELAND, OH / ACCESSWIRE / September 29, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that it will be conducting a series of interviews with its corporate lea
- 4y agoXSNXNovAccess Global Announces Effectiveness of Form S-1 Registration StatementACCESS NewswireIncludes 7.5 Million Shares for Innovest Global Share Distribution Increases Unaffiliated Float While Significantly Expanding Shareholder Base CLEVELAND, OH / ACCESSWIRE / September 22, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company de
- 4y agoXSNXNovAccess Global Announces Uplisting to OTCQBACCESS NewswireCLEVELAND, OH / ACCESSWIRE / August 10, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that the trading of its common shares has been upgraded to the OTC Markets
- 4y agoXSNXNovAccess Global, Inc.'s CEO to attend BIO Conference in New YorkACCESS NewswireCLEVELAND, OH / ACCESSWIRE / February 15, 2022 / NovAccess Global, Inc. (OTC:XSNX) announced that its CEO Dr. Dwain Irvin to attend the BIO (Biotechnology innovation organization) CEO and investor conference in New York, NY, which runs from February 14-1
- 4y agoXSNXNovAccess Global, Inc. Names Neil Laird, Chief Financial OfficerACCESS NewswireCLEVELAND, OH / ACCESSWIRE / December 8, 2021 / NovAccess Global, Inc. (OTC:XSNX) welcomes new Chief Financial Officer (CFO), Neil Laird. "I am pleased to welcome Neil Laird to the management team," said Dr. Dwain Irvin, Chief Executive Officer, NovAcce
- 4y agoGXXMIVSTXSNXInnovest Global, Inc. to Accelerate Objectives; GPC Capital and New LeadershipACCESS NewswireCLEVELAND, OH / ACCESSWIRE / November 19, 2021 / Innovest Global, Inc. (OTC:IVST), a diversified industrials company, announced today that GPC Holdings has obtained a voting majority in the Company with plans to catalyze growth and achieve the goals stat
- 5y agoXSNXNovAccess Global, Inc. Expands Advisory BoardACCESS NewswireCLEVELAND, OH / ACCESSWIRE / October 6, 2021 / NovAccess Global, Inc. (OTC:XSNX) announced the expansion of its Advisory Board by adding Dr. Kim Seroogy. Dr. Kim Seroogy is currently Professor of Neurology and Director of The Selma Schottenstein Harris
- 5y agoXSNXNovAccess Global, Inc. CEO Interviewed On MoneyTVACCESS NewswireCLEVELAND, OH / ACCESSWIRE / September 15, 2021 / NovAccess Global, Inc. (OTC:XSNX) announced Dr. Dwain Irvin's interview on MoneyTV aired on September 11, 2021. MoneyTV has been in the business for 25 years, reaching 200 million homes in 75 countries.
- 5y agoXNDAXSNXThis Week on MoneyTV with Donald Baillargeon, 9/10ACCESS NewswireHOLLYWOOD, CA / ACCESSWIRE / September 10, 2021 / Cancer treatment breakthroughs, self-driving cars, restaurant hypocrisy; this week on MoneyTV with Donald Baillargeon MoneyTV is the internationally syndicated television program all about money and what
- 5y agoXSNXNovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World CongressACCESS NewswireCLEVELAND, OH / ACCESSWIRE / July 8, 2021 / NovAccess Global, Inc. (OTC:XSNX) announced it has been invited to present at the Society for Brain Mapping and Therapeutics (SBMT) 18th World Congress, which runs from July 8-11, 2021. The conference is focuse
- 5y agoXSNXNovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDAACCESS NewswireCLEVELAND, OH / ACCESSWIRE / June 29, 2021 / NovAccess Global Inc. (OTC:XSNX) announced today that it received a productive response from the U.S. Food and Drug Administration (FDA) on its pre-investigational new drug (IND) meeting request regarding the
- 5y agoXSNXNovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021ACCESS NewswireCLEVELAND, OH / ACCESSWIRE / June 8, 2021 / NovAccess Global, Inc. (OTC:XSNX) (the 'Company' or 'NovAccess'), a cancer therapeutics company with operations in biotechnology, is pleased to announce that it has filed the Form 10-K annual filing for the fis